Innovative Facility for Isotope GENeration with Efficient Ion Accelerator

The IFIGENEIA Excellence Hub aspires to introduce, develop and deliver the complete design study and the precise business plan for the implementation in Europe of the LINear ACcelerator (LINAC) technology in radiation therapy, diagnostic and theranostic procedures.

Linear Accelerator technologies offer a unique, compact, cost-effective, and environmentally friendly solution for sustainable production, management, accessibility, and promotion of nuclear medicine and molecular imaging technologies.Unlike current radioisotope production methods, mostly reliant on older nuclear reactors using highly enriched uranium with associated concerns about global availability, safety, and environmental issues, or on cyclotrons limited to a narrow range of radioisotopes, LINACs enable the production of a broader range due to their tunability in energy, targets, and currents.

The IFIGENEIA Excellence Hub aims to create the complete design and implementation study for a cutting-edge LINAC facility in the Balkans, by creating in Greece, Slovenia and Cyprus Excellence Hubs dedicated to developing and implement a LINAC-based facility, capable of producing a diverse range of marketable radioisotopes.

Interconnected Hubs will collaboratively pursue national and international partnerships to achieve shared strategic goals and improve value chains.

The project focuses on a cross-border R&I strategy, an investment plan, and implementing innovative products and services across the hubs.

Each Hub will unite regional stakeholders in healthcare, culture, academia, businesses, public sectors, and societal actors, working toward sustainable nuclear medicine and culture in their regions.

IFIGENEIA aims to incubate future excellence hubs in the West Balkan region and will provide mentoring to West Balkan countries in the current project.In collaboration with esteemed research centers, IFIGENEIA can create a lasting technological and business framework for nuclear medicine in Europe.